SOURCE: GeneThera, Inc.

September 21, 2006 19:31 ET

MN1 Research Issues GTHA, Inc. Buy Recommendation

DALLAS, TX -- (MARKET WIRE) -- September 21, 2006 -- GTHA, Inc. (OTCBB: GTHA) -- Market News First ( -- Analyst Mike Willingham has updated his recent GTHA, Inc. research report. His Evaluation analysis has led him to issue a buy recommendation based on historical and fundamental metrics. The complete report is available on the Market News First website: Come join us tomorrow Friday, September 22nd, at 11:30 am CDT on

Dr. Tony Milici, GTHA, Inc. President, said, "GTHA is pleased that the Market News First review of the Company has resulted in a positive analysis and buy recommendation." The United States is developing a growing awareness of genetics-based diagnostics for agricultural and veterinary markets. The company develops molecular assays for the detection of diseases in live animals, including mad cow disease among cattle, and chronic wasting disease in elk and deer. The company is currently focusing on the two molecular laboratories they are planning to open outside the US to treat cattle for mad cow disease and Johnne's disease. One lab will be located in Mexico where they will be focusing on Johnne's disease while the other lab in Italy will focus on mad cow and Scrapie diseases, as well. In addition, it is in the process of developing therapeutic vaccines for the detection and prevention of food contaminating pathogens, veterinary diseases, and diseases affecting human health. The company is based in Wheat Ridge, Colorado. GTHA is committed to being at the forefront of the effort to make more relevant to the modern lifestyle of its patrons. Our products are designed to meet the desires of this changing marketplace.


Market News First is an online market news provider bringing investors current news on the public stock market arena. Market News First is the only online live radio web site that brings real market news to investors and features live interaction with companies from the Bulletin Board to NYSE.

This press release may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. The words "estimate," "possible" and "seeking" and similar expressions identify forward-looking statements, which speak only as to the date the statement was made. The company undertakes no obligation to publicly update or revise any forward-looking statements, whether because of new information, future events, or otherwise. Forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted, or quantified. Future events and actual results could differ materially from those set forth in, contemplated by, or underlying the forward-looking statements. The risks and uncertainties to which forward-looking statements are subject include, but are not limited to the effect of government regulation, competition and other material risks.

Contact Information

  • Contact:

    Mark Gage
    Market News First
    469-385-9855 ex. 863